Discovery of Pemigatinib: A Potent and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor.

MLA

Wu, Liangxing, et al. “Discovery of Pemigatinib: A Potent and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor.” Journal of Medicinal Chemistry, vol. 64, no. 15, Aug. 2021, pp. 10666–79. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.1c00713.

APA

Wu, L., Zhang, C., He, C., Qian, D., Lu, L., Sun, Y., Xu, M., Zhuo, J., Liu, P. C. C., Klabe, R., Wynn, R., Covington, M., Gallagher, K., Leffet, L., Bowman, K., Diamond, S., Koblish, H., Zhang, Y., Soloviev, M., … Yao, W. (2021). Discovery of Pemigatinib: A Potent and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor. Journal of Medicinal Chemistry, 64(15), 10666–10679. https://doi.org/10.1021/acs.jmedchem.1c00713

Chicago

Wu, Liangxing, Colin Zhang, Chunhong He, Dingquan Qian, Liang Lu, Yaping Sun, Meizhong Xu, et al. 2021. “Discovery of Pemigatinib: A Potent and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor.” Journal of Medicinal Chemistry 64 (15): 10666–79. doi:10.1021/acs.jmedchem.1c00713.